NEW YORK (GenomeWeb News) – Opko Health has acquired Prost-Data, a Nashville, Tenn.-based CLIA laboratory doing business under the name OURLab.

Opko said that the acquisition would provide it with a commercial platform to support the US commercial launch of its 4Kscore protein biomarker prostate cancer test. The 4kscore test employs two protein biomarkers in the kallikrein family along with prostate-specific antigen for early detection of prostate cancer.

The lab has 18 phlebotomy sites throughout the US and a national sales force calling on urologists.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.

A retrovirus that's been integrated into the human genome appears to have a role in embryonic development, researchers report.

A report from MIT identifies areas of scientific research where declining research support is hindering needed advances.